AI Article Synopsis

  • The extracellular matrix (ECM) is important in cancer because it can help tumors grow and make treatments less effective.
  • Scientists studied lung cancer tissue to find differences in the ECM between cancerous and normal tissues.
  • They discovered 161 proteins related to the ECM that can help identify lung cancer and found some new markers that could predict how well patients might do after treatment.

Article Abstract

Introduction: The composition and remodelling of the extracellular matrix (ECM) are important factors in the development and progression of cancers, and the ECM is implicated in promoting tumour growth and restricting anti-tumour therapies through multiple mechanisms. The characterisation of differences in ECM composition between normal and diseased tissues may aid in identifying novel diagnostic markers, prognostic indicators and therapeutic targets for drug development.

Methods: Using tissue from non-small cell lung cancer (NSCLC) patients undergoing curative intent surgery, we characterised quantitative tumour-specific ECM proteome signatures by mass spectrometry.

Results: We identified 161 matrisome proteins differentially regulated between tumour tissue and nearby non-malignant lung tissue, and we defined a collagen hydroxylation functional protein network that is enriched in the lung tumour microenvironment. We validated two novel putative extracellular markers of NSCLC, the collagen cross-linking enzyme peroxidasin and a disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAMTS16), for discrimination of malignant and non-malignant lung tissue. These proteins were up-regulated in lung tumour samples, and high and gene expression was associated with shorter survival of lung adenocarcinoma and squamous cell carcinoma patients, respectively.

Discussion: These data chart extensive remodelling of the lung extracellular niche and reveal tumour matrisome signatures in human NSCLC.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313119PMC
http://dx.doi.org/10.3389/fonc.2023.1194515DOI Listing

Publication Analysis

Top Keywords

tumour matrisome
8
matrisome signatures
8
non-small cell
8
lung
8
cell lung
8
lung cancer
8
non-malignant lung
8
lung tissue
8
lung tumour
8
tumour
6

Similar Publications

Modulating cell-free DNA biology as the next frontier in liquid biopsies.

Trends Cell Biol

December 2024

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.

Technical advances over the past two decades have enabled robust detection of cell-free DNA (cfDNA) in biological samples. Yet, higher clinical sensitivity is required to realize the full potential of liquid biopsies. This opinion article argues that to overcome current limitations, the abundance of informative cfDNA molecules - such as circulating tumor DNA (ctDNA) - collected in a sample needs to increase.

View Article and Find Full Text PDF

The extracellular matrix (ECM) is a complex meshwork comprising over 100 proteins. It serves as an adhesive substrate for cells and, hence, plays critical roles in health and disease. We have recently identified a novel ECM protein, SNED1, and have found that it is required for neural crest cell migration and craniofacial morphogenesis during development and in breast cancer, where it is necessary for the metastatic dissemination of tumor cells.

View Article and Find Full Text PDF

Deep multi-omics integration approach reveals new molecular features of uterine leiomyosarcoma.

Biochim Biophys Acta Mol Basis Dis

December 2024

Universidade Federal do Rio Grande do Norte, IMD, Ppg-Bioinformatica, Natal, Brazil; University of Southern California, Keck School of Medicine, Department of Translational Genomics, 1450 Biggy St., Los Angeles, CA 90089, United States of America. Electronic address:

Uterine leiomyosarcoma (uLMS) is a rare and aggressive cancer representing approximately 25 % of all uterine malignancies. The molecular heterogeneity and pathogenesis of uLMS are not well understood, and translational studies aimed at discovering the vulnerabilities of this tumor type are of high priority. We conducted an innovative comprehensive multi-omics integration study from DNA to protein using freshly frozen tumors.

View Article and Find Full Text PDF
Article Synopsis
  • The study analyzed the proteomic profiles of 79 bladder cancer samples, categorizing them into non-muscle-invasive (NMIBC), muscle-invasive (MIBC), and neoadjuvant-treated MIBC groups.
  • MIBC showed significant changes in the extracellular matrix and immune response-related proteins, as well as a decrease in proteins related to cell adhesion and lipid metabolism compared to NMIBC.
  • The research identified multiple proteomic subgroups within MIBC and NMIBC that correlate with tissue type and metabolic pathways, revealing complex tumor-stroma interactions and significant genomic alterations in the cancers.
View Article and Find Full Text PDF

Recent approaches of regenerative reproductive medicine investigate the decellularized extracellular matrix to develop a transplantable engineered ovary (TEO). However, a full proteomic analysis is not usually performed after the decellularization process to evaluate the preservation of the extracellular matrix (ECM). In this study, the ECM of the bovine ovarian cortex was analyzed before and after decellularization using mass spectrometry and bioinformatics.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!